Your Feed

Filter by
See content from
Back to the latest
Thumbnail for Acalabrutinib vs Zanubrutinib for Relapsed/Refractory CLL |  Adam Kittai, MD | ASCO 2023
Playlist: ASCO 2023

Acalabrutinib vs Zanubrutinib for Relapsed/Refractory CLL | Adam Kittai, MD | ASCO 2023

Video details & playlist